Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.

Activist investor Glenview Capital Management has reduced its ownership stake in CVS Health (NYSE:CVS) after the pharmacy ...

Activist investor Glenview Capital said on Tuesday it reduced its holdings in CVS Health by 3.75 million shares after the ...

CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better ...

CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped ...

CVS Health ( NYSE: CVS) on Thursday announced plans to discontinue operations in the individual health insurance business, ...

We recently published a list of Jim Cramer Reveals Trump’s Potential Secret Weapon In China Trade Talks & Discusses These 10 ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

(Reuters) - CVS Health raised its full-year profit forecast on Thursday following strong performance across its businesses, ...

Shareholders appeared unconcerned with CVS Health Corporation's (NYSE:CVS) lackluster earnings report last week. Our analysis suggests that while the profits are soft, the foundations of the ...

CVS Health (CVS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

Discussing the various changes over at CVS Health Corporation (NYSE:CVS), Cramer said: ...